PA006000: Rabbit Anti-Human IgG Monoclonal Antibody
Rabbit Monoclonal Antibody;
Applications: ELISA, Western Blot, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays;
Specificity/Sensitivity: The recombinant rabbit anti-human IgG monoclonal antibody (clone: 32RA04) specifically recognizes human immunoglobulin isotypes (IgG1, IgG2, IgG3, IgG4), total IgG and IgG-Fab but NOT Cynomolgus macaque total IgG, Rhesus macaque total IgG, Marmoset total IgG, Mouse total IgG, and Rat total IgG.BP003918: Biotinylated Human/Mouse/Goat Cpn10/HSPE1 Protein with the N-His-Avi Tag
Source: The recombinant Biotinylated Human/Mouse/Goat Cpn10/HSPE1 Protein, (amino acids Ala2-Asp102) fused with a His-Avi tag at the N-terminus, was produced in E.coli cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP003919: Human/Mouse/Goat Cpn10/HSPE1 Protein with the N-His-Avi Tag
Source: The recombinant Human/Mouse/Goat Cpn10/HSPE1 Protein, (amino acids Ala2-Asp102) fused with a His-Avi tag at the N-terminus, was produced in E.coli cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP003053: Recombinant SARS-CoV-2 Nucleocapsid Protein-His-Avi (NP Protein, N Protein)
Source: E.coli.
Purity: > 95% by PAGE under reduced condition.BP003083: Recombinant Human Nectin-3 / CD113 Protein
Source: mammalian cells.
Purity: > 95% by Bis-Tris PAGE and HPLC.BP003080: Recombinant Human LILRB4 / CD85k / ILT3 Protein
Source: mammalian cells.
Purity: > 95% by Bis-Tris PAGE and HPLC.BP003081: Recombinant Human LILRA2 / CD85h / ILT1 Protein
Source: mammalian cells.
Purity: > 95% by Bis-Tris PAGE and HPLC.APIM050010: AV-951 (TIVOZANIB)
CAS No.: 475108-18-0.
Purity: 99% (HPLC).
QC: LC/MS, 1HNMR.
Solubility: Soluble in DMSO.APIM050010: AV-951 (TIVOZANIB)
CAS No.: 475108-18-0.
Purity: 99% (HPLC).
QC: LC/MS, 1HNMR.
Solubility: Soluble in DMSO.Fast turnaround: 8-10 weeks in total. Our antibody humanization process involves significant computational analysis, and thus is quite efficient and requires much less trial time.
A human antibody database and a proprietary method are used for analysis and design of humanized antibodies.
Nine humanized antibodies (each combination of 3 designed heavy chains and 3 designed light chains) are constructed and produced for antigen binding confirmation and affinity measurement.